Video
17 May 2024

Panel: Reshoring US Pharma: The Realities

Join us as our experts delve into the current state of pharmaceutical manufacturing on American soil, examining the drivers, challenges, and outcomes of the onshoring trend within the US pharma industry

  • Examining case studies and success stories that highlight the progress and challenges in realizing onshoring goals within the US pharma market
  • Analyzing the impact of regulatory changes and supply chain disruptions on onshoring efforts
  • Assessing hybrid Onshoring and Nearshoring

Content provided by our supplier

United States Pharmacopeia Standard R&D and Technical Service (Shanghai) Co., Ltd.

  • US
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Other

Other Content from United States Pharmacopeia Standard R&D and Technical Service (Shanghai) Co., Ltd. (7)

  • News A Day in the Life of a Managing Director

    We are continuing to get to know the people working day-to-day behind the pharma companies shaping the industry, the ones who keep the wheels turning and ultimately bring better healthcare to the population; we are talking to the individuals at the heart of pharma.
  • Brochure USP Ingredient Verification Program for APIs

    This handout highlights how the USP Ingredient Verification Program helps ensure the quality of active pharmaceutical ingredients (APIs).
  • Video Panel: Reshoring US Pharma: The Realities

    Join us as our experts delve into the current state of pharmaceutical manufacturing on American soil, examining the drivers, challenges, and outcomes of the onshoring trend within the US pharma industry. In this session you will: Examine case studies and success stories that highlight the progress and challenges in realizing onshoring goals within the US pharma market Analyze the impact of regulatory changes and supply chain disruptions on onshoring efforts Assess hybrid Onshoring and Nearshoring
  • Video Navigating Drug Pricing Dynamics in the Supply Chain Economy

    Reviewing the outcome of the inflation reduction act and how it is affecting pharmaceutical manufacturers and distributors in managing drug pricing within the supply chain, including:
    Examining broader economic and market trends influencing drug pricing within the supply chain economy and their effects across US Healthcare
  • Video Key Elements to Building a More Resilient Supply Chain

    Leveraging Data Analytics for Build a More Resilient Supply Chain. Today, patients in the United States and around the world depend on medicines—and the ingredients used to make those medicines—sourced from and manufactured around the globe. The recent pandemic, geopolitical, and natural events have not only led to medicine shortages but have also exposed systemic pharmaceutical supply chain vulnerabilities. Understanding and addressing these vulnerabilities require a systematic approach to building a more resilient supply chain: Understanding supply chain challenges Implementing solutions to supply chain challenges Detect problems and predict risk through data analytics Provide recommendations to address and alleviate the risks Solve problems through advanced manufacturing technologies Scale solutions through collaborative partnerships
  • Video Utilizing Data Analytics for Optimized Pharmaceutical Supply Chains

    Data analytics is playing an increasingly important role in helping companies achieve supply chain excellence. By collecting and analyzing data, companies can gain insights into their supply chains that can help them improve efficiency, reduce costs, and improve customer service How Data analytics can be used to track and trace shipments, identify bottlenecks, and optimize inventory levels Data analytics can also be used to predict demand, forecast future trends, and identify risks By using data analytics, companies can make better decisions about their supply chains, which can lead to improved efficiency, reduced costs, and improved customer service
  • Video The Supply Chain is Broken. What Will It Take to Fix It?

    The story of how patient advocacy, patient centric design, and partnership is rebuilding the global pharmecutical supply chain to ensure access to all.